BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people ...

I-Mab, a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies ...

The song, "Moodeng Moodeng," was released in English, Thai, Chinese and Japanese. It's available for streaming on Spotify, ...

This centre embodies the long-standing relationship between the UAE and King’s College Hospital London Dubai – King’s College ...

Our fitness experts and editors tested more than two dozen of the best cross-training shoes from brands like NoBull and Ryka ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...

Nome, ALASKA — Scientists aboard a U.S. Coast Guard icebreaker have discovered something unusual in the Arctic Ocean: a ...

Project S.W.E.A.T.? (Skill and Work Ethic Aren?t Taboo), will be auctioned in Scottsdale from January 18 to 26, 2025, with ...

Former Sinn Fein press officer Michael McMonagle has been jailed for nine months after pleading guilty to child sex ...

Lawyers for the state of Louisiana asked a federal appeals court Wednesday to immediately block a judge's ruling ordering education officials to tell all local districts that a law requiring schools ...

BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Wednesday reported a loss of $36.7 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of 18 ...